Skip to the main content.

Products & Services
AI Technology
- LENS^ai Applications
- The LENS^ai Difference
Applications
- Insights
Resources
Partnership
Company
- Overview
- Leadership
- Investor Relations
- Careers
- Locations
- Contact Us
- News
- Events
Online Store

Search

Search

Products & Services
AI Technology
- LENS^ai Applications
- The LENS^ai Difference
Applications
- Insights
Resources
Partnership
Company
- Overview
- Leadership
- Investor Relations
- Careers
- Locations
- Contact Us
- News
- Events
Online Store

HUB of
Biotherapeutic
Intelligence™

Antibody Discovery Services

Overview
Target Analysis & Immunization
Antibody Discovery & Characterization
Developability Profiling
Optimization & Engineering
Preclinical Services

Protein Production

Online Store

See our latest upcoming event

Tell me more to Events

to Events

Connect with IPA

Contact us to Contact
Follow us on LinkedIn to LinkedIn

HUB of
Biotherapeutic
Intelligence™

AI Technology

LENS^ai Applications
The LENS^ai Difference

See our latest upcoming event

Tell me more to Events

to Events

Connect with IPA

Contact us to Contact
Follow us on LinkedIn to LinkedIn

HUB of
Biotherapeutic
Intelligence™

Applications

See our latest upcoming event

Tell me more to Events

to Events

Connect with IPA

Contact us to Contact
Follow us on LinkedIn to LinkedIn

HUB of
Biotherapeutic
Intelligence™

Resources

Antibody Discovery Resources
AI Technology Resources
IPA Collective
Resource Spotlight

See our latest upcoming event

Tell me more to Events

to Events

Connect with IPA

Contact us to Contact
Follow us on LinkedIn to LinkedIn

HUB of
Biotherapeutic
Intelligence™

Company

Overview
Leadership
Investor Relations
Careers
Locations
Contact Us

News

News & Press Releases
Events

See our latest upcoming event

Tell me more to Events

to Events

Connect with IPA

Contact us to Contact
Follow us on LinkedIn to LinkedIn

IPA Leadership

Contact Us

ENGINEERED for the Biotherapeutic Race

IPA’s subsidiary BioStrand unveils major breakthrough with advanced Foundation AI Model utilizing LLM stacking and HYFT technology

Hub of biotherapeutic intelligence

Joseph Scheffler

Joseph Scheffler

Interim Chief Financial Officer

Bio Coming

IPA News

Connect with IPA

Products & Services
Applications
- Insights
Company
- Overview
- Leadership
- Investor Relations
- News
- Events
- Careers
AI Technology
- LENS^ai Overview
- The LENS^ai Difference
Resources
Connect
- Contact Us
- Locations

Follow Us
LinkedIn
Twitter
YouTube

Sign-up for latest news, blogs and more

Privacy
Legal Notice
Cookie Policy

© 2025 ImmunoPrecise Antibodies Ltd. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies Ltd. BioStrand is a trademark of BioStrand, BV. BioStrand BV is an independently operating subsidiary of ImmunoPrecise Antibodies Ltd.